RT @doctorRBC: Rates of MACE and VTE with upadacitinib were infrequent and consistent with background rates in RA, PsA a
Tweet Content
Rates of MACE and VTE with upadacitinib were infrequent and consistent with background rates in RA, PsA and AS patients. Factors associated with MACE/VTE: age>65, HTN, DM, smoking, history CV event/VTE
Abs#0510 @RheumNow #ACR22 https://t.co/AjtJF0p3QK
Show on Archive Page
On
Display in Search Results
On
PDQ
Off